Literature DB >> 7350709

Closure of colostomy following sigmoid colon resection for perforated diverticulitis.

G A Bell.   

Abstract

Hartmann resection has been the treatment of choice for perforated diverticulitis of the sigmoid colon at the Vancouver General Hospital for nearly 20 years. A retrospective analysis of 70 patients who had the colonic stomas closed following the Hartmann resection was done. A modified Hartmann resection for the initial procedure has been recommended on the basis of fewer complication and shorter hospital stay when the closure operation is performed. The modification consists of the creation of a distal mucus fistula rather than suturing the rectum closed. To facilitate the creation of a distal mucus fistula, it is suggested that less sigmoid colon be resected at the time of the initial operation. The colon can be assessed for residual diverticular disease later and more resected at the later closure operation if required.

Entities:  

Mesh:

Year:  1980        PMID: 7350709

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  5 in total

1.  Gasless video-assisted reversal of Hartmann's procedure.

Authors:  G Navarra; S Occhionorelli; D Marcello; V Bresadola; M Santini; M Rubbini
Journal:  Surg Endosc       Date:  1995-06       Impact factor: 4.584

2.  A totally diverting loop colostomy.

Authors:  N D Merrett; P C Gartell
Journal:  Ann R Coll Surg Engl       Date:  1993-07       Impact factor: 1.891

3.  Experience with early anastomosis after the Hartmann procedure.

Authors:  J G Geoghegan; I L Rosenberg
Journal:  Ann R Coll Surg Engl       Date:  1991-03       Impact factor: 1.891

4.  Same admission colostomy closure (SACC). A new approach to rectal wounds: a prospective study.

Authors:  B M Renz; D V Feliciano; R Sherman
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

5.  Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.